Serum aspartate aminotransferase is an adverse prognostic indicator for patients with resectable pancreatic ductal adenocarcinoma.
Meifang HeYin LiuHefei HuangJiali WuJuehui WuRuizhi WangDong WangPublished in: Laboratory medicine (2023)
Preoperative AST levels could be a novel independent prognostic biomarker for patients with PDAC. The incorporation of AST levels into a nomogram with TNM staging can be an accurate predictive model for OS in patients with resectable PDAC.